Whether EGFR tyrosine kinase inhibitors or ALK inhibitors are still effective for these special lung adenocarcinomas with clear cell component like lung adenocarcinoma is uncertain and calls for further investigation [13]. The gene discussed is ALK; the disease is lung adenocarcinoma.